{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:15:53Z","timestamp":1791670553880,"version":"4.3.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107003","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T19:01:07Z","timestamp":1409943667000},"page":"e107003","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Importance of Fatty Acid Compositions in Patients with Peripheral Arterial Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Milan","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Motoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"MH Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2008.07.060","article-title":"Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality","volume":"52","author":"MH Criqui","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"110","author":"E Selvin","year":"2004","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.3731","article-title":"Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS)","volume":"17","author":"H Ohnishi","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2004.05.028","article-title":"Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study","volume":"177","author":"T Fujiwara","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5551\/jat.7682","article-title":"Albuminuria as a risk factor for peripheral arterial disease in a general population: the Hisayama study","volume":"18","author":"T Usui","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/oxfordjournals.aje.a009817","article-title":"Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study","volume":"149","author":"RR Fabsitz","year":"1999","journal-title":"Am J Epidemiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9149(03)00537-X","article-title":"Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index","volume":"92","author":"MM McDermott","year":"2003","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"PM Ridker","year":"2001","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9149(01)01603-4","article-title":"Association of C-reactive protein with markers of prevalent atherosclerotic disease","volume":"88","author":"AR Folsom","year":"2001","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.19.10.2355","article-title":"Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries","volume":"19","author":"M Erren","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-158-7-201304020-00003","article-title":"Plasma phospholipid long-chain \u03c9-3 fatty acids and total and cause-specific mortality in older adults: a cohort study","volume":"158","author":"D Mozaffarian","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2007.03.018","article-title":"Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events","volume":"193","author":"WS Harris","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archinte.165.2.193","article-title":"Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids","volume":"165","author":"DE Laaksonen","year":"2005","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(84)91044-4","article-title":"Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men","volume":"2","author":"DA Wood","year":"1984","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2013.09.023","article-title":"Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study","volume":"231","author":"T Ninomiya","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0003319712437031","article-title":"Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease","volume":"64","author":"M Fujihara","year":"2013","journal-title":"Angiology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1253\/circj.CJ-08-1197","article-title":"Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease","volume":"73","author":"M Matsuzaki","year":"2009","journal-title":"Circ J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1253\/circj.CJ-11-0941","article-title":"Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention","volume":"76","author":"T Domei","year":"2012","journal-title":"Circ J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1205409","article-title":"n-3 fatty acids in patients with multiple cardiovascular risk factors","volume":"368","author":"MC Roncaglioni","year":"2013","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","article-title":"Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis","volume":"308","author":"EC Rizos","year":"2012","journal-title":"JAMA"},{"key":"ref22","volume":"153","unstructured":"Eichler K, Puhan MA, Steurer J, Bachmann LM (2007) Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J <volume>153<\/volume>: : 722\u201331, 731."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1253\/circj.70.1249","article-title":"Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population","volume":"70","year":"2006","journal-title":"Circ J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version","volume":"20","author":"T Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1253\/circj.71.995","article-title":"Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan","volume":"71","author":"T Yamazaki","year":"2007","journal-title":"Circ J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/hr.2010.93","article-title":"Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease","volume":"33","author":"M Endo","year":"2010","journal-title":"Hypertens Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jvs.2010.02.008","article-title":"The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease","volume":"52","author":"H Kumakura","year":"2010","journal-title":"J Vasc Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.atherosclerosis.2013.04.030","article-title":"Body mass index is inversely associated with mortality in patients with peripheral vascular disease","volume":"229","author":"J Golledge","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"F Thies","year":"2003","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"D Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n-3 and n-6 fatty acids","volume":"47","author":"G Schmitz","year":"2008","journal-title":"Prog Lipid Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.11.008","article-title":"Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives","volume":"197","author":"WS Harris","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2013.10.014","article-title":"Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome","volume":"232","author":"D Tousoulis","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell&apos;Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"L Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"M Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease","volume":"74","author":"Y Ishikawa","year":"2010","journal-title":"Circ J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctim.2013.06.006","article-title":"Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients","volume":"21","author":"S Rezapour-Firouzi","year":"2013","journal-title":"Complement Ther Med"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Jung JY, Kwon HH, Hong JS, Yoon JY, Park MS, <etal>et al<\/etal>.. (2014) Effect of Dietary Supplementation with Omega-3 Fatty Acid and gamma-linolenic Acid on Acne Vulgaris: A Randomised, Double-blind, Controlled Trial. Acta Derm Venereol.","DOI":"10.2340\/00015555-1802"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5551\/jat.No430","article-title":"Anti-atherosclerotic effects of dihomo-gamma-linolenic acid in ApoE-deficient mice","volume":"16","author":"S Takai","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0952-3278(93)90030-Z","article-title":"Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats","volume":"49","author":"MM Engler","year":"1993","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.ATV.15.9.1397","article-title":"Dietary gamma-linolenic acid modulates macrophage-vascular smooth muscle cell interactions. Evidence for a macrophage-derived soluble factor that downregulates DNA synthesis in smooth muscle cells","volume":"15","author":"YY Fan","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0261-5614(98)80318-X","article-title":"Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease","volume":"17","author":"GC Leng","year":"1998","journal-title":"Clin Nutr"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"SC Smith","year":"2011","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","volume":"33","author":"J Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"g2272","DOI":"10.1136\/bmj.g2272","article-title":"Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys","volume":"348","author":"R Micha","year":"2014","journal-title":"BMJ"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.108.191627","article-title":"Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention","volume":"119","author":"WS Harris","year":"2009","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2013.11.048","article-title":"Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study","volume":"232","author":"F Marangoni","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.plefa.2004.06.001","article-title":"Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients","volume":"71","author":"JI Harris","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1074248412473202","article-title":"Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease","volume":"18","author":"T Nozue","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:29:03Z","timestamp":1588976943000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107003"}},"subtitle":[],"editor":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,5]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107003","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,5]]}}}